A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Stopped early · Phase 2

Conditions studied: Rheumatoid Arthritis

In brief

This is a continuation trial of LymphoStat-B™ to evaluate the long-term safety in subjects with Rheumatoid Arthritis that completed study LBRA01 and benefitted from treatment.

Key facts

Study ID
NCT00583557
Run by
Human Genome Sciences Inc.
People needed
155
Starts
2005-01-01
Expected to finish
2009-11-01
Last updated by the study team
2013-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.